Clinical trial · Observational
Pediatric Oncological Orthopaedic Reconstruction
Pediatric Oncological Orthopaedic Reconstruction : "Analysis of the Clinical and Radiographic Results"
NCT06522165CI-TRIAL-00092934active not recruitingClinicalTrials.gov clinicaltrialsProvenance
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 8, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260908-000001
Summary
Brief summary (as posted)
From the archives of the Rizzoli institute all the children undergoing oncological reconstruction from 1991 to 2023 (approximately 400 patients). A review will be made of the medical records, radiological imaging, and histological data of these patients
Conditions
Conditions (2)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Bone Cancer | Malignant Bone Neoplasm | ALIAS | 0.90 |
| Bone Tumor | Bone Neoplasm | ALIAS | 0.90 |
Interventions
Interventions (1)
| Intervention | Type | Mapped drug | Match |
|---|---|---|---|
| Analysis | Other | — | UNRESOLVED |
Design
Arms and outcomes
Arms (1)
- label
- patients
- description
- Male and female patients surgically treated with an oncological reconstructions at Rizzoli Orthopaedic Institute between 01/01/1991 and 31/12/2023
- interventionNames
- Other: Analysis
Primary outcomes (1)
- measure
- longevity of the reconstruction
- timeFrame
- at baseline (day 0)
- description
- -assess the longevity associated with pediatric oncologic reconstructions;
Secondary outcomes (1)
- measure
- complications
- timeFrame
- at baseline (day 0)
- description
- assess the complications associated with pediatric oncologic reconstructions;
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 2 Years
- Maximum age
- 17 Years
Show eligibility criteria text
Inclusion Criteria: * Diagnosis of bone sarcoma * Patients with available clinical and imaging data Exclusion Criteria: * At least one inclusion criteria not met
References
Publications (3)
- BACKGROUNDAbdeen A, Hoang BH, Athanasian EA, Morris CD, Boland PJ, Healey JH. Allograft-prosthesis composite reconstruction of the proximal part of the humerus: functional outcome and survivorship. J Bone Joint Surg Am. 2009 Oct;91(10):2406-15. doi: 10.2106/JBJS.H.00815. PMID 19797576
- BACKGROUNDAponte-Tinao LA, Ayerza MA, Muscolo DL, Farfalli GL. Allograft reconstruction for the treatment of musculoskeletal tumors of the upper extremity. Sarcoma. 2013;2013:925413. doi: 10.1155/2013/925413. Epub 2013 Feb 14. PMID 23476115
- BACKGROUNDAzoury SC, Shammas RL, Othman S, Sergesketter A, Brigman BE, Nguyen JC, Arkader A, Weber KL, Erdmann D, Levin LS, Kovach SJ, Innocenti M. Outcomes following Free Fibula Physeal Transfer for Pediatric Proximal Humerus Reconstruction: An International Multi-Institutional Study. Plast Reconstr Surg. 2023 Apr 1;151(4):805-813. doi: 10.1097/PRS.0000000000010001. Epub 2022 Dec 6. PMID 36729876